Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Novartis
Citi
Express Scripts
Baxter
Federal Trade Commission
Chinese Patent Office
Argus Health
Accenture
Queensland Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075383

« Back to Dashboard

NDA 075383 describes CYTARABINE, which is a drug marketed by Fresenius Kabi Usa, Hong Kong, Hospira, Mylan Labs Ltd, Teva Parenteral, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from five suppliers. Additional details are available on the CYTARABINE profile page.

The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 075383
Tradename:CYTARABINE
Applicant:Hospira
Ingredient:cytarabine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 075383
Medical Subject Heading (MeSH) Categories for 075383
Suppliers and Packaging for NDA: 075383
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYTARABINE cytarabine INJECTABLE;INJECTION 075383 ANDA Hospira, Inc. 61703-319 N 61703-319-22

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Nov 22, 1999TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Covington
Harvard Business School
McKinsey
Healthtrust
Chubb
UBS
US Army
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot